OUR MISSION

To empower the global healthcare ecosystem through innovation

Predicine is a molecular insight company developing genomic profiling tests and robust algorithms for cancer diagnostics and monitoring. Our biology-oriented approach to analyzing genomics is advancing the understanding of tumor mutational landscape.

Our passion

At Predicine, we are passionate about our people, technology, and creating a lasting impact in cancer research. 

 

People

Passionate, fearless and committed talent is our key strength. 35% of our team are PhDs.

 

Technology

We are leading the innovation in urine-based diagnostics.

 

Profound impact

Helping patients worldwide in clinical trials and easy cancer detection.

Our values and culture

Predicine is the culmination of talented people coming together to realize a shared vision. Our culture is dynamic, fast-paced, energetic and innovative. We innovate boldly and have an endless pursuit for quality. We stick by our values to carry out our important roles because we know that the work we do every day impacts real lives.

COMPANY VALUES

  • Integrity
  • Innovation
  • Quality
  • Respect
  • Courage
  • Collaboration
  • Caring
  • Communication

Leadership

Shidong Jia | CEO

Shidong Jia, MD, PhD, is the Founder and CEO of Predicine. Prior to founding Predicine, Shidong spearheaded the oncology biomarker strategies and drug & diagnostics co-development at Genentech. His previous work identified p110beta as novel drug target for PTEN-deficient tumors, a finding that laid the foundation for clinical development and testing of p110beta inhibitors in cancers. He previously held various senior research positions focusing on translational and clinical cancer research at Novartis Institutes for BioMedical Research and Harvard University. Shidong was awarded the P.A.R.T. Investigatorship Award from the Dana-Farber Cancer Institute. Shidong holds a MD and PhD from Harbin Medical University and Peking Union Medical College, and completed postdoctoral training at the Dana-Farber Cancer Institute – Harvard University.

Pan Du | President

Pan Du, PhD, is the Co-founder, President and CTO at Predicine. Pan is an expert in next-generation sequencing, bioinformatics, and oncology diagnostics. He has developed multiple widely used bioinformatics analysis software and has authored numerous publications, including several 1st authorship manuscripts that are cited over thousands times. Prior to Predicine, Pan was Principal Scientist at Roche Diagnostics and Senior Computational Biologist at Genentech. He was previously an Assistant Professor at Biomedical Informatics Center at Northwestern University. Pan holds a PhD with distinction in both Bioinformatics and Electrical Engineering from Iowa State University.

Linh H. Le | CFO

Linh Le joined Predicine as Chief Financial Officer in November 2021. He brings more than 2 decades of work experience in the healthcare space, stemming from several industry sectors including medical device, biopharmaceutical, and molecular diagnostics. Linh comes to Predicine from Ambry Genetics, where he served as Chief Operating Officer, leading key transformational changes that enabled scalability and operational excellence across the enterprise during his tenure. His prior experience includes Medtronic Diabetes Group, where he has held various leadership positions of increased responsibilities over a span of fourteen years. Before his time at Medtronic, Linh’s experiences include leadership roles at the Walt Disney Company and advisory services with PricewaterhouseCoopers, where he specialized in operational and systems risk management. Lastly, Linh began his professional career in the assurance practice of KPMG, providing services in the technology and healthcare practices where he earned his CPA designation. Linh holds a Bachelor of Science degree in Business Administration from California State University at Northridge. Linh was named LA Times CFO of the year in 2022.

CAREERS

Join the fight against cancer

If you enjoy challenges, collaborating with others to solve complex problems, and the chance to see your work impact the millions of lives touched by cancer, this is the place to be.

PERKS

• Employee benefits include comprehensive Medical, Dental, Vision, 401K

• Paid Time Off

• A generous employee referral program

• Ample employee parking

• Happy Hour and quarterly team building events 

• Close to 92 Bridge, easy access to HWY 880

View our open positions here

News & Events

LABORATORY

Our molecular genetics lab

We have a CAP-accredited and CLIA-certified laboratory in Hayward, California that uses the most cutting-edge technologies and instruments including Illumina MiniSeq™, Illumina NextSeq™, and Illumina NovaSeq™ 6000 System.   Our high-caliber laboratory staff bring a wealth of sequencing and sample expertise to ensure accuracy and reliability of results.

Predicine’s licenses and accreditations:

3555 Arden Road, Hayward CA 94545

  • CAP: 8169662
  • CLIA: 05D2148483
  • State of California: CDF-00351747
  • State of Maryland: 2906
  • State of Rhode Island: LCO01259
  • State of Pennsylvania: 36601
  • State of New York: PFI 9740

3555 Arden Road, Hayward CA 94545

  • CAP: 9327228
  • CLIA: 05D2258469
  • State of California: CDF-90006452

15366 Park Row, Houston TX 77084

  • CAP: 9307089
  • CLIA: 45D2260063

1314 North Plum Grove Road, Schaumburg IL 60173

  • CAP: 9307136
  • CLIA: 14D2256972

Contact us

If you have any questions or need assistance, our customer support team is on-hand to help.

FAX

+1-650-332-9181

ADDRESS

3555 Arden Road
Hayward, CA 94545, USA

ADDRESS

1698 Wangyuan Road, Building 11
Shanghai, 201499, China

Get in touch

We would love to hear from you. Please use the form below to submit your questions, comments, or inquries about potential partnerships.